​Prof. Christopher Hodges​
Oxford University

Christopher Hodges is Professor of Justice Systems at the University of Oxford; Head of the Swiss Re/CMS Research Programme on Civil Justice Systems at the Centre for Socio-Legal Studies, University of Oxford; a Supernumerary Fellow of Wolfson College, Oxford; and a (non-practising) solicitor. From 2011-2014 he was Erasmus Professor of the Fundamentals of Private Law at Erasmus University, Rotterdam. From 2013 to 2016 he is Honorary Professor at China’s leading law faculty at the China University of Political Science and Law, Beijing and Guest Professor at China’s leading international law faculty, Wuhan University, Wuhan. In 2013 he was Visiting Professor at Leuven University’s Global Law School Programme and in 2014 Visiting Fellow at the Australian National University, Canberra.

His research is directed at reviewing all EU regulatory and dispute resolution systems to devise an integrated civil justice and regulatory model for European states. His books include Law and Corporate Behaviour: Integrating Theories of Regulation and Enforcement (Hart, 2015), Consumer ADR in Europe (Hart, 2012), The Costs and Funding of Civil Litigation (Hart, 2010), The Reform of Class and Representative Actions in European Legal Systems: A New Approach to Collective Redress in Europe (Hart, 2008), European Regulation of Consumer Product Safety (Oxford, 2005), Multi-Party Actions (Oxford, 2001), and European Product Liability (1993).

He graduated from New College, Oxford in 1976, obtained his PhD from King’s College, London in 2003, and worked from 1977 to 2003 in major City of London law firms, with a pan-EU practice. His advice has been sought by the European Commission, European Parliament, numerous governments, regulatory authorities, ombudsmen, multinational businesses and consumer associations across the world.

He is co-coordinator of the pan-EU Civil Justice Systems Project, and the Stanford-Oxford Global Class Actions Project. He has a special interest in health systems, is a Board Member of the UK Research Integrity Office, and has chaired various committees in the sector, including the Pharmaceutical Services Negotiating Committee for England.